Its not just about the number on the scale
Members seeking approval for these weight loss drugs should engage in lifestyle changes such as diet and exercise, with expectations of regular follow-ups with their healthcare provider to track progress
GLP1s+ Summary In the last 30 years, weve gone from no GLP1s+ or truly scalable weight loss treatments to having treatments that: Efficacy: help patients lose 22% (and still rising) of their weight on average, up from 3-5% Disease Expansion: are approved for diabetes, obesity, cardiovascular disease and soon likely kidney disease and sleep apnea, with more conditions under study Frequency: are taken 1x/week, down from 2x/day (52 times per year versus 730) Form Factor: can be taken orally with more effective options on the horizon Improving the form factor, reducing the burden placed on the patient, all while maintaining and increasing efficacy across weight loss and other cardiometabolic measures, these are incredible feats of science that will benefit humanity in ways we cannot yet comprehend, especially once prices decline
Este enfoque permite que el sistema digestivo se adapte gradualmente y reduce el riesgo de distensin abdominal, gases o calambres
Benzodiazepines are 1,4-diazepine ring structures
